Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Immunol ; 39(12): 719-27, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12531283

ABSTRACT

Our previous study showed that recombinant canine IL-13 (rcaIL-13) stimulated production of allergen-specific IgE in vitro by peripheral blood mononuclear cells (PBMC) from flea allergen-sensitized dogs. This has also been demonstrated using human IL-13 (huIL-13) and PBMC isolated from human allergy patients. The stimulatory activity of rcaIL-13 was specifically inhibited by a fusion protein of the extracellular domain of canine IL-13Ralpha2 and the Fc fragment of canine IgG heavy chain (rcaIL-13Ralpha2-Fc). In this communication, we report the construction and expression of a non-fused recombinant extracellular domain of canine IL-13Ralpha2 (rcaIL-13Ralpha2) in an E. coli expression system. The E. coli expressed rcaIL-13Ralpha2 was isolated in inclusion bodies, then solubilized in buffer containing denaturants and reducing agents. After refolding and purification, the biological activity of rcaIL-13Ralpha2 was found in the monomer fraction resulting from gel filtration and ion exchange chromatographies. Biological activity of purified rcaIL-13Ralpha2 was demonstrated by the specific inhibition of rcaIL-13 activity in a TF-1 cell proliferation assay. Additionally, rcaIL-13Ralpha2 was found to be active in neutralizing rcaIL-13 induced upregulation of IgE mRNA levels in PBMCs of "high IgE" dogs, which have been bred to exhibit a predisposition for high IgE production and are used as a model for allergic asthma. The data confirm our previous report that the regulatory effects of IL-13 on IgE production in canine PBMCs are similar to those reported in humans. Thus, allergic dogs, such as the "high IgE" producing dogs, may be excellent models for research on IgE-mediated diseases in humans.


Subject(s)
Receptors, Interleukin/genetics , Allergens , Animals , Asthma/genetics , Asthma/immunology , Base Sequence , Cell Line , DNA, Complementary/genetics , Dogs , Escherichia coli/genetics , Gene Expression , Humans , Immunoglobulin E/biosynthesis , In Vitro Techniques , Interleukin-13/pharmacology , Interleukin-13 Receptor alpha1 Subunit , Leukocytes, Mononuclear/immunology , Protein Folding , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Interleukin/biosynthesis , Receptors, Interleukin/chemistry , Receptors, Interleukin-13 , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/genetics
2.
Vet Immunol Immunopathol ; 89(1-2): 13-27, 2002 Oct 08.
Article in English | MEDLINE | ID: mdl-12208047

ABSTRACT

Type I interferons (IFN) are important mediators of the host defense against viral infections in mammals. In humans multiple subtypes of IFN-alpha exist, most of which possess antiviral activity. Little is known about the type I IFN genes in cats and the role they may play in feline immunological responses to viruses. We have isolated cDNAs encoding five feline IFN-alpha (feIFN) subtypes that share from 95 to 99% amino acid sequence identity. FeIFN-alpha5 has five additional amino acids inserted at position 139, which are not present in the other four subtypes. Sequence identity of the feIFN proteins encoded by the five clones compared to human IFN-alpha2 is approximately 60%. Unlike most of the human subtypes, each of the five feline IFN sequences has an N-glycosylation recognition site. Expression of all five feIFN-alpha subtypes in Chinese hamster ovary (CHO) cells was confirmed by Western blot analysis, and all resulting proteins were glycosylated. The antiviral activity of each feIFN-alpha subtype produced in transiently transfected CHO cell cultures was tested in vitro. In addition, subtype feIFN-alpha6 was expressed in the yeast, Pichia pastoris. The resulting secreted mature recombinant protein was purified and demonstrated significant antiviral activity and induction of 2',5'-oligoadenylate synthetase activity in vitro.


Subject(s)
Cats/immunology , Interferon Type I/genetics , 2',5'-Oligoadenylate Synthetase/biosynthesis , Amino Acid Sequence , Animals , Base Sequence , Blotting, Western/veterinary , CHO Cells , Cats/genetics , Cloning, Molecular , Cricetinae , Escherichia coli/genetics , Escherichia coli/metabolism , Interferon Type I/chemistry , Interferon Type I/pharmacology , Molecular Sequence Data , Pichia/genetics , Pichia/metabolism , RNA/chemistry , RNA/genetics , Recombinant Proteins , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Vesicular stomatitis Indiana virus/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...